Physician profile
Andrew Trunk
NPI 1942706312
$1,590.28
in general payments reported to CMS, 2019-2025
9 companies · $800 in 2025
The $800 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.97 · 2022: $99.99 · 2023: $326 · 2024: $264 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083 · Education: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.80 |
| Education | $307.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $448.23 | 2025 | Niktimvo, Jakafi, Jakafi |
| Seagen INC. | $317.89 | 2021-2023 | Tukysa |
| National Marrow Donor Program | $222.29 | 2025 | |
| Astellas Pharma US INC | $131.98 | 2023 | |
| Jazz Pharmaceuticals INC. | $129.53 | 2025 | |
| Pfizer INC. | $124.55 | 2024 | |
| Tempus Ai, INC | $123.44 | 2024 | |
| Lilly USA, LLC | $76.54 | 2023 | |
| Novartis Pharmaceuticals Corporation | $15.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Trunk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.